Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases

Immunol Allergy Clin North Am. 2006 May;26(2):365-77, ix. doi: 10.1016/j.iac.2006.02.002.

Abstract

Based on the hygiene hypothesis association between atopy and bacillus Calmette-Guerin (BCG), purified protein derivative skin test reaction, mycobacterial disease, and environmental mycobacteria are summarized. The role of mycobacterial species in the activation of the innate immune response through Toll-like receptors is mentioned. The implications and perspectives of BCG as a potential therapeutic adjuvant in atopic disease are discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adjuvants, Immunologic*
  • Adolescent
  • Animals
  • BCG Vaccine / immunology*
  • Child
  • Child, Preschool
  • Dermatitis, Atopic / immunology*
  • Humans
  • Immunologic Factors / immunology*
  • Mice
  • Mycobacterium bovis / immunology*
  • Tuberculin / immunology

Substances

  • Adjuvants, Immunologic
  • BCG Vaccine
  • Immunologic Factors
  • Tuberculin